Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 58

1.

Risk of Severe Maternal Morbidity or Death in Relation to Prenatal Biochemical Screening: Population-Based Cohort Study.

Lentz EJM, Park AL, Langlois AWR, Huang T, Meschino WS, Ray JG.

Am J Perinatol. 2019 Aug 14. doi: 10.1055/s-0039-1694731. [Epub ahead of print]

PMID:
31412403
2.

International trends in the uptake of cancer risk reduction strategies in women with a BRCA1 or BRCA2 mutation.

Metcalfe K, Eisen A, Senter L, Armel S, Bordeleau L, Meschino WS, Pal T, Lynch HT, Tung NM, Kwong A, Ainsworth P, Karlan B, Moller P, Eng C, Weitzel JN, Sun P, Lubinski J, Narod SA; Hereditary Breast Cancer Clinical Study Group.

Br J Cancer. 2019 Jul;121(1):15-21. doi: 10.1038/s41416-019-0446-1. Epub 2019 Apr 11.

PMID:
30971774
3.

Hormone Levels in Pregnancy and Subsequent Risk of Maternal Breast and Ovarian Cancer: A Systematic Review.

Iqbal J, Kahane A, Park AL, Huang T, Meschino WS, Ray JG.

J Obstet Gynaecol Can. 2019 Feb;41(2):217-222. doi: 10.1016/j.jogc.2018.03.133. Epub 2018 Oct 24. Review.

PMID:
30528445
4.

BAFopathies' DNA methylation epi-signatures demonstrate diagnostic utility and functional continuum of Coffin-Siris and Nicolaides-Baraitser syndromes.

Aref-Eshghi E, Bend EG, Hood RL, Schenkel LC, Carere DA, Chakrabarti R, Nagamani SCS, Cheung SW, Campeau PM, Prasad C, Siu VM, Brady L, Tarnopolsky MA, Callen DJ, Innes AM, White SM, Meschino WS, Shuen AY, Paré G, Bulman DE, Ainsworth PJ, Lin H, Rodenhiser DI, Hennekam RC, Boycott KM, Schwartz CE, Sadikovic B.

Nat Commun. 2018 Nov 20;9(1):4885. doi: 10.1038/s41467-018-07193-y.

5.

Real-world health services utilisation and outcomes after BRCA1 and BRCA2 testing in Ontario, Canada: the What Comes Next Cohort Study protocol.

Dossa F, Cusimano MC, Sutradhar R, Metcalfe K, Little T, Lerner-Ellis J, Eisen A, Meschino WS, Baxter NN.

BMJ Open. 2018 Sep 4;8(9):e025317. doi: 10.1136/bmjopen-2018-025317.

6.

Evolution of genetic assessment for BRCA-associated gynaecologic malignancies: a Canadian multisociety roadmap.

McCuaig JM, Stockley TL, Shaw P, Fung-Kee-Fung M, Altman AD, Bentley J, Bernardini MQ, Cormier B, Hirte H, Kieser K, MacMillan A, Meschino WS, Panabaker K, Perrier R, Provencher D, Schrader KA, Serfas K, Tomiak E, Wong N, Young SS, Gotlieb WH, Hoskins P, Kim RH; BRCA TtoT Community of Practice.

J Med Genet. 2018 Sep;55(9):571-577. doi: 10.1136/jmedgenet-2018-105472. Epub 2018 Jul 24.

7.

Enhanced First Trimester Aneuploidy Screening with Placental Growth Factor and Alpha Feto-Protein: Detection of Trisomies 18 and 13.

Huang T, Meschino WS, Rashid S, Dennis A, Mak-Tam E, Cuckle H.

J Obstet Gynaecol Can. 2018 Oct;40(10):1295-1301. doi: 10.1016/j.jogc.2018.01.007. Epub 2018 Jul 17.

PMID:
30025867
8.

Prenatal biochemical screening and long term risk of maternal cardiovascular disease: population based cohort study.

Ray JG, Huang T, Meschino WS, Cohen E, Park AL.

BMJ. 2018 Jul 11;362:k2739. doi: 10.1136/bmj.k2739. Erratum in: BMJ. 2018 Aug 15;362:k3540.

9.

Physical activity during adolescence and young adulthood and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers.

Lammert J, Lubinski J, Gronwald J, Huzarski T, Armel S, Eisen A, Meschino WS, Lynch HT, Snyder C, Eng C, Olopade OI, Ginsburg O, Foulkes WD, Elser C, Cohen SA, Kiechle M, Narod SA, Kotsopoulos J.

Breast Cancer Res Treat. 2018 Jun;169(3):561-571. doi: 10.1007/s10549-018-4694-1. Epub 2018 Feb 5.

PMID:
29404807
10.

Genetic assessment wait time indicators in the High Risk Ontario Breast Screening Program.

Eisen A, Blackmore KM, Meschino WS, Muradali D, Carroll JC, Majpruz V, Warner E, Rabeneck L, Chiarelli AM.

Mol Genet Genomic Med. 2018 Mar;6(2):213-223. doi: 10.1002/mgg3.359. Epub 2018 Jan 25.

11.

Enhanced First Trimester Screening for Trisomy 21 with Contingent Cell-Free Fetal DNA: A Comparative Performance and Cost Analysis.

Huang T, Meschino WS, Teitelbaum M, Dougan S, Okun N.

J Obstet Gynaecol Can. 2017 Sep;39(9):742-749. doi: 10.1016/j.jogc.2017.01.025. Epub 2017 Jun 16.

PMID:
28624447
12.

Disruption of YWHAE gene at 17p13.3 causes learning disabilities and brain abnormalities.

Noor A, Bogatan S, Watkins N, Meschino WS, Stavropoulos DJ.

Clin Genet. 2018 Feb;93(2):365-367. doi: 10.1111/cge.13056. Epub 2017 Aug 31.

PMID:
28542865
13.

Feasibility of computerized working memory training in individuals with Huntington disease.

Sadeghi M, Barlow-Krelina E, Gibbons C, Shaikh KT, Fung WLA, Meschino WS, Till C.

PLoS One. 2017 Apr 28;12(4):e0176429. doi: 10.1371/journal.pone.0176429. eCollection 2017.

14.

Supporting genetics in primary care: investigating how theory can inform professional education.

Wilson BJ, Islam R, Francis JJ, Grimshaw JM, Permaul JA, Allanson JE, Blaine S, Graham ID, Meschino WS, Ramsay CR, Carroll JC.

Eur J Hum Genet. 2016 Nov;24(11):1541-1546. doi: 10.1038/ejhg.2016.68. Epub 2016 Jun 22.

15.

Incidental detection of familial APP duplication: an unusual reason for a false positive NIPT result of trisomy 21.

Meschino WS, Miller K, Bedford HM.

Prenat Diagn. 2016 Apr;36(4):382-4. doi: 10.1002/pd.4783. Epub 2016 Feb 24. No abstract available.

PMID:
26844948
16.

First trimester screening for Down syndrome using nuchal translucency, maternal serum pregnancy-associated plasma protein A, free-β human chorionic gonadotrophin, placental growth factor, and α-fetoprotein.

Huang T, Dennis A, Meschino WS, Rashid S, Mak-Tam E, Cuckle H.

Prenat Diagn. 2015 Jul;35(7):709-16. doi: 10.1002/pd.4597. Epub 2015 May 19.

PMID:
25846403
17.

Pilot Testing of a Psycho-educational Telephone Intervention for Women Receiving Uninformative BRCA1/2 Genetic Test Results.

Maheu C, Meschino WS, Hu W, Honeyford J, Ambus I, Kidd M, Benea A, Gao X, Azadbakhsh M, Rochefort C, Esplen MJ.

Can J Nurs Res. 2015 Mar;47(1):53-71. doi: 10.1177/084456211504700105. English, French.

PMID:
29509450
18.

First and second trimester maternal serum markers in pregnancies with a vanishing twin.

Huang T, Boucher K, Aul R, Rashid S, Meschino WS.

Prenat Diagn. 2015 Jan;35(1):90-6. doi: 10.1002/pd.4492. Epub 2014 Oct 5.

PMID:
25200921
19.

Effectiveness of screening with annual magnetic resonance imaging and mammography: results of the initial screen from the ontario high risk breast screening program.

Chiarelli AM, Prummel MV, Muradali D, Majpruz V, Horgan M, Carroll JC, Eisen A, Meschino WS, Shumak RS, Warner E, Rabeneck L.

J Clin Oncol. 2014 Jul 20;32(21):2224-30. doi: 10.1200/JCO.2013.52.8331. Epub 2014 Jun 16.

PMID:
24934793
20.

The impact of maternal weight discrepancies on prenatal screening results for Down syndrome.

Huang T, Meschino WS, Okun N, Dennis A, Hoffman B, Lepage N, Rashid S, Aul R, Farrell SA.

Prenat Diagn. 2013 May;33(5):471-6. doi: 10.1002/pd.4090. Epub 2013 Mar 20.

PMID:
23512612
21.

Maternal age-based prenatal screening for chromosomal disorders: attitudes of women and health care providers toward changes.

Carroll JC, Rideout A, Wilson BJ, Allanson J, Blaine S, Esplen MJ, Farrell S, Graham GE, MacKenzie J, Meschino WS, Prakash P, Shuman C, Taylor S, Tobin S.

Can Fam Physician. 2013 Jan;59(1):e39-47.

22.

Evaluating genetic counseling for individuals with schizophrenia in the molecular age.

Costain G, Esplen MJ, Toner B, Scherer SW, Meschino WS, Hodgkinson KA, Bassett AS.

Schizophr Bull. 2014 Jan;40(1):78-87. doi: 10.1093/schbul/sbs138. Epub 2012 Dec 12.

23.

Phenotypic heterogeneity of genomic disorders and rare copy-number variants.

Girirajan S, Rosenfeld JA, Coe BP, Parikh S, Friedman N, Goldstein A, Filipink RA, McConnell JS, Angle B, Meschino WS, Nezarati MM, Asamoah A, Jackson KE, Gowans GC, Martin JA, Carmany EP, Stockton DW, Schnur RE, Penney LS, Martin DM, Raskin S, Leppig K, Thiese H, Smith R, Aberg E, Niyazov DM, Escobar LF, El-Khechen D, Johnson KD, Lebel RR, Siefkas K, Ball S, Shur N, McGuire M, Brasington CK, Spence JE, Martin LS, Clericuzio C, Ballif BC, Shaffer LG, Eichler EE.

N Engl J Med. 2012 Oct 4;367(14):1321-31. doi: 10.1056/NEJMoa1200395. Epub 2012 Sep 12. Erratum in: N Engl J Med. 2012 Dec 13;367(24):2362.

24.

De novo germline and postzygotic mutations in AKT3, PIK3R2 and PIK3CA cause a spectrum of related megalencephaly syndromes.

Rivière JB, Mirzaa GM, O'Roak BJ, Beddaoui M, Alcantara D, Conway RL, St-Onge J, Schwartzentruber JA, Gripp KW, Nikkel SM, Worthylake T, Sullivan CT, Ward TR, Butler HE, Kramer NA, Albrecht B, Armour CM, Armstrong L, Caluseriu O, Cytrynbaum C, Drolet BA, Innes AM, Lauzon JL, Lin AE, Mancini GM, Meschino WS, Reggin JD, Saggar AK, Lerman-Sagie T, Uyanik G, Weksberg R, Zirn B, Beaulieu CL; Finding of Rare Disease Genes (FORGE) Canada Consortium, Majewski J, Bulman DE, O'Driscoll M, Shendure J, Graham JM Jr, Boycott KM, Dobyns WB.

Nat Genet. 2012 Jun 24;44(8):934-40. doi: 10.1038/ng.2331.

25.

GenetiKit: a randomized controlled trial to enhance delivery of genetics services by family physicians.

Carroll JC, Wilson BJ, Allanson J, Grimshaw J, Blaine SM, Meschino WS, Permaul JA, Graham ID.

Fam Pract. 2011 Dec;28(6):615-23. doi: 10.1093/fampra/cmr040. Epub 2011 Jul 10.

PMID:
21746696
26.

Genotype-phenotype analysis of the branchio-oculo-facial syndrome.

Milunsky JM, Maher TM, Zhao G, Wang Z, Mulliken JB, Chitayat D, Clemens M, Stalker HJ, Bauer M, Burch M, Chénier S, Cunningham ML, Drack AV, Janssens S, Karlea A, Klatt R, Kini U, Klein O, Lachmeijer AM, Megarbane A, Mendelsohn NJ, Meschino WS, Mortier GR, Parkash S, Ray CR, Roberts A, Roberts A, Reardon W, Schnur RE, Smith R, Splitt M, Tezcan K, Whiteford ML, Wong DA, Zori R, Lin AE.

Am J Med Genet A. 2011 Jan;155A(1):22-32. doi: 10.1002/ajmg.a.33783.

PMID:
21204207
27.

Genetics: factor V Leiden.

Cremin C, Carroll JC, Allanson J, Blaine SM, Dorman H, Gibbons CA, Honeywell C, Meschino WS, Permaul J, Wilson BJ.

Can Fam Physician. 2010 Apr;56(4):353. No abstract available.

28.

Mitogenic cardiomyopathy: a lethal neonatal familial dilated cardiomyopathy characterized by myocyte hyperplasia and proliferation.

Chang KT, Taylor GP, Meschino WS, Kantor PF, Cutz E.

Hum Pathol. 2010 Jul;41(7):1002-8. doi: 10.1016/j.humpath.2009.12.008. Epub 2010 Mar 29.

PMID:
20303141
29.

Genetics: Preimplantation genetic diagnosis.

Gibbons CA, Allanson J, Blaine SM, Cremin C, Dorman H, Honeywell C, Meschino WS, Permaul J, Carroll JC.

Can Fam Physician. 2010 Mar;56(3):247. No abstract available.

30.

Genetics: familial melanoma.

Cremin C, Blaine SM, Allanson J, Dorman H, Gibbons CA, Honeywell C, Meschino WS, Permaul J, Carroll JC.

Can Fam Physician. 2010 Jan;56(1):31. No abstract available.

31.

Genetics: schizophrenia.

Rideout AL, Carroll JC, Blaine SM, Cremin C, Dorman H, Gibbons CA, Honeywell C, Meschino WS, Permaul J, Allanson J.

Can Fam Physician. 2009 Dec;55(12):1207. No abstract available.

32.

Genetics: Hypertrophic cardiomyopathy.

Honeywell C, Meschino WS, Allanson J, Blaine SM, Cremin C, Dorman H, Gibbons CA, Permaul J, Carroll JC.

Can Fam Physician. 2009 Nov;55(11):1095. No abstract available.

33.

Genetics: Newborn screening for sickle cell anemia.

Meschino WS, Gibbons CA, Allanson J, Blaine SM, Cremin C, Dorman H, Honeywell C, Permaul J, Wilson BJ, Carroll JC.

Can Fam Physician. 2009 Oct;55(10):1001. No abstract available.

34.

Genetics: type 2 diabetes.

Dorman H, Meschino WS, Allanson J, Blaine SM, Cremin C, Gibbons CA, Honeywell C, Permaul J, Carroll JC.

Can Fam Physician. 2009 Sep;55(9):893. No abstract available.

35.

Genetics: prostate cancer.

Blaine SM, Honeywell C, Allanson J, Cremin C, Dorman H, Gibbons CA, Meschino WS, Permaul J, Carroll JC.

Can Fam Physician. 2009 Jul;55(7):710. No abstract available.

36.

Genetics: Alzheimer disease.

Dorman H, Meschino WS, Allanson J, Blaine SM, Cremin C, Gibbons CA, Honeywell C, Permaul J, Carroll JC.

Can Fam Physician. 2009 Jun;55(6):603. No abstract available.

37.

Not on the face alone: perception of contextualized face expressions in Huntington's disease.

Aviezer H, Bentin S, Hassin RR, Meschino WS, Kennedy J, Grewal S, Esmail S, Cohen S, Moscovitch M.

Brain. 2009 Jun;132(Pt 6):1633-44. doi: 10.1093/brain/awp067. Epub 2009 May 18.

38.

Genetics: newborn screening for MCAD deficiency.

Carroll JC, Gibbons CA, Blaine SM, Cremin C, Dorman H, Honeywell C, Meschino WS, Permaul J, Allanson J.

Can Fam Physician. 2009 May;55(5):487. Review. No abstract available.

39.

Genetics: Codeine metabolism.

Gibbons CA, Blaine SM, Allanson J, Cremin C, Dorman H, Honeywell C, Meschino WS, Permaul J, Carroll JC.

Can Fam Physician. 2009 Feb;55(2):164. No abstract available.

40.

Genetics: hereditary hemochromatosis.

Allanson J, Honeywell C, Blaine SM, Cremin C, Dorman H, Gibbons CA, Grimshaw J, Meschino WS, Permaul J, Wilson BJ, Carroll JC.

Can Fam Physician. 2009 Jan;55(1):53. No abstract available.

41.

Hereditary breast and ovarian cancers.

Carroll JC, Cremin C, Allanson J, Blaine SM, Dorman H, Gibbons CA, Grimshaw J, Honeywell C, Meschino WS, Permaul J, Wilson BJ.

Can Fam Physician. 2008 Dec;54(12):1691-2. Review. No abstract available.

42.

Fetal Alert Network: Surveying congenital anomalies.

Meschino WS.

Paediatr Child Health. 2007 May;12(5):365-6. No abstract available.

43.

Clinical management recommendations for surveillance and risk-reduction strategies for hereditary breast and ovarian cancer among individuals carrying a deleterious BRCA1 or BRCA2 mutation.

Horsman D, Wilson BJ, Avard D, Meschino WS, Kim Sing C, Plante M, Eisen A, Howley HE, Simard J; National Hereditary Cancer Task Force.

J Obstet Gynaecol Can. 2007 Jan;29(1):45-60.

PMID:
17346477
44.

Age at first birth and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers.

Kotsopoulos J, Lubinski J, Lynch HT, Klijn J, Ghadirian P, Neuhausen SL, Kim-Sing C, Foulkes WD, Moller P, Isaacs C, Domchek S, Randall S, Offit K, Tung N, Ainsworth P, Gershoni-Baruch R, Eisen A, Daly M, Karlan B, Saal HM, Couch F, Pasini B, Wagner T, Friedman E, Rennert G, Eng C, Weitzel J, Sun P, Narod SA; Hereditary Breast Cancer Clinical Study Group, Garber J, Osborne M, Fishman D, McLennan J, McKinnon W, Merajver S, Olsson H, Provencher D, Pasche B, Evans G, Meschino WS, Lemire E, Chudley A, Rayson D, Bellati C.

Breast Cancer Res Treat. 2007 Oct;105(2):221-8. Epub 2007 Jan 24.

PMID:
17245541
45.

Surveillance of BRCA1 and BRCA2 mutation carriers with magnetic resonance imaging, ultrasound, mammography, and clinical breast examination.

Warner E, Plewes DB, Hill KA, Causer PA, Zubovits JT, Jong RA, Cutrara MR, DeBoer G, Yaffe MJ, Messner SJ, Meschino WS, Piron CA, Narod SA.

JAMA. 2004 Sep 15;292(11):1317-25.

PMID:
15367553
46.

Genetics and insurance.

Meschino WS.

CMAJ. 2004 Aug 31;171(5):432. No abstract available.

47.

Subtelomeric deletions of chromosome 9q: a novel microdeletion syndrome.

Stewart DR, Huang A, Faravelli F, Anderlid BM, Medne L, Ciprero K, Kaur M, Rossi E, Tenconi R, Nordenskjöld M, Gripp KW, Nicholson L, Meschino WS, Capua E, Quarrell OW, Flint J, Irons M, Giampietro PF, Schowalter DB, Zaleski CA, Malacarne M, Zackai EH, Spinner NB, Krantz ID.

Am J Med Genet A. 2004 Aug 1;128A(4):340-51.

PMID:
15264279
48.

Educating women about breast cancer. An intervention for women with a family history of breast cancer.

Warner E, Carroll JC, Heisey RE, Goel V, Meschino WS, Lickley HL, Doan BD, Chart PL, Orr V, Lothian S.

Can Fam Physician. 2003 Jan;49:56-63.

49.

The child with developmental delay: An approach to etiology.

Meschino WS.

Paediatr Child Health. 2003 Jan;8(1):16-9.

50.

Genetic analysis of patients with the Saethre-Chotzen phenotype.

Chun K, Teebi AS, Jung JH, Kennedy S, Laframboise R, Meschino WS, Nakabayashi K, Scherer SW, Ray PN, Teshima I.

Am J Med Genet. 2002 Jun 15;110(2):136-43.

PMID:
12116251

Supplemental Content

Loading ...
Support Center